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Impaired On/Off Regulation of TNF Biosynthesis
in Mice Lacking TNF AU-Rich Elements: Implications
for Joint and Gut-Associated Immunopathologies
protein (Perez et al., 1990; Grell et al., 1995; Alexopoulou
et al., 1997) by transducing differential signals ranging
from cellular activation and proliferation to cytotoxicity
and apoptosis through two distinct TNF receptors, p55
(TNFRI) and p75 (TNFRII) (Vandenabeele et al., 1995).
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Athens 115 21 Strong TNF producers include mainly cells of the my-
Greece eloid lineage such as monocytes and macrophages. In
²Division of Gastroenterology and Hepatology addition, a large variety of other cell types, both hemo-
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Charlottesville, Virginia 22906 TNF, including a number of carcinoma cell lines (for
review see Vassalli, 1992).
Considering the pleiotropism of TNF actions, it is not
Summary surprising that its biosynthesis is under the control of
multiple and complex regulatory mechanisms. TNF tran-
We addressed the impact of deleting TNF AU-rich ele- scription is under the control of several factors such as
ments (ARE) from the mouse genome on the regulation NF-kB and NF-AT (Collart et al., 1990; Goldfeld et al.,
of TNF biosynthesis and the physiology of the host. 1991). Moreover, ample evidence has indicated addi-
Absence of the ARE affected mechanisms responsible tional translational controls residing at the 39-UTR of
for TNF mRNA destabilization and translational re- TNF mRNA. Experiments using reporter constructs
pression in hemopoietic and stromal cells. In stimu- transfected into cultured cell lines have implicated the
lated conditions, TNF ARE were required both for the 39-UTR region of TNF mRNA in the translationally re-
alleviation and reinforcement of message destabiliza- pressed state in which TNF transcripts are found in
tion and translational silencing. Moreover, the mutant nonstimulated conditions (Han et al., 1990). This type of
mRNA was no longer responsive to translational mod- blockade was suggested to be permanent in stromal
ulation by the p38 and JNK kinases, demonstrating cell types (Kruys et al., 1993) but readily reversible upon
that TNF ARE are targets for these signals. Develop- appropriate stimulation in tissues of hemopoietic origin
ment of two specific pathologies in mutant mice, i.e., (Beutler et al., 1986; Han et al., 1990). Although evidence
chronic inflammatory arthritis and Crohn's-like inflam- on proximal factors regulating TNF biosynthesis is
matory bowel disease, suggests that defective func- scarce, translational activation of TNF mRNA in hemo-
tion of ARE may be etiopathogenic for the develop- poietic tissues is shown to occur via the action of stress-
ment of analogous human pathologies. activated protein kinases (SAPK) (Lee et al., 1994; Swan-
tek et al., 1997). However, the specific target sequences
on TNF mRNA accepting such modulatory signals haveIntroduction
not yet been defined.
Alterations in the patterns of TNF production haveMechanisms regulating mRNA stability and translation
been associated with many inflammatory and autoim-are driven by specific elements carried on mRNA se-
mune pathological processes (Vassalli, 1992; van De-quences. One major class of these regulatory sequences
venter, 1997). More specifically, the dominant role ofconsists of adenosine-uracil multimers with a character-
TNF in the pathogenesis of rheumatoid arthritis (RA)istic AUUUA pentanucleotide and as such are referred
and idiopathic inflammatory bowel diseases (IBD), ofto as AU-rich elements (ARE). These ARE have been
currently unknown etiology, has been demonstrated bymapped in the 39-untranslated region (39-UTR) of tran-
recent successful clinical trials using anti-TNF antibod-scripts encoding cytokines, oncoproteins, and growth
ies (Elliott et al., 1994; Targan et al., 1997). However,and transcription factors (Caput et al., 1986) For some
little is known about the molecular mechanisms thatmRNAs, including those encoding IL-2, c-fos, and GM-
may result in aberrant TNF expression in either RA orCSF, the function of the ARE has been strongly associ-
IBD. Evidence for a potential role of the 39-UTR of TNF inated with the regulation of mRNA stability (Chen and
arthritis comes from studies using mice carrying 39-UTR-Shyu, 1995; Chen et al., 1998). In addition, a paradigm
modified human TNF transgenes (Keffer et al., 1991).for translational regulation by the ARE has been estab-
Furthermore, in spontaneous murine models of autoim-lished for a number of mRNAs (Kruys et al., 1989).
munity such as in the NZB/W mice, reduced levels ofTumor necrosis factor (TNF) plays a central role in
TNF, which appear to be pathogenic, are associatedvarious immune and inflammatory phenomena (Vassalli,
with mutations in TNF ARE sequences (Jacob et al.,1992; Pasparakis et al., 1996a). TNF exerts its bioactivity
either as a transmembrane molecule or as a soluble 1996). It is therefore conceivable that interference at the
level of ARE functioning may be etiopathogenic in vivo.
In the present study, we have directly assessed the in³ To whom correspondence should be addressed (e-mail: giorgos_
vivo impact of the deletion of TNF ARE sequences onkollias@hol.gr).
both the regulation of TNF biosynthesis and the physiol-§ Present address: Institute for Genetics, University of Cologne,
50931 Cologne, Germany. ogy of the host.
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Chronic Overproduction of TNF in TNFDARE Mice
and Increased Sensitivity to Endotoxemia
Examination of TNFDARE sera for murine TNF using a
specific ELISA revealed that circulating TNF protein was
present in significant quantities in all mutant mice tested.
Homozygous TNFDARE/DARE mice produce as much as 822
(6 447) pg/ml of murine TNF at 6 weeks of age, while
in heterozygous TNFDARE/1 or TNFDARE/2 mice values varied
between 90 and 430 pg/ml. Normal TNF1/1 or TNF1/2
control mice did not show detectable levels of circulat-
ing TNF. Serum TNF levels in disease-free TNFDARE/DARE/
TNFRI2/2 mice were at the range of 300 6 160 pg/ml.
Furthermore, circulating TNF protein levels in the sera
of both TNFDARE/2 and TNF1/2 mice were rapidly in-
creased 90 min following LPS administration, reaching
three times higher values in the TNFDARE/2 mice (3.4 6
1.07 ng/ml in TNF1/2 versus 11.53 6 5.4 ng/ml in TNFDARE/2
mice). These data demonstrate an overall suppressive
role of the ARE on TNF production, resulting in the in-
creased constitutive and inducible production of TNF in
the animal. To examine the effect of TNF overproduction
on the acute lethal effects of bacterial endotoxin, we
compared lethality in TNFDARE/2 and TNF1/2 mice follow-
ing challenge with varying doses of LPS. TNFDARE/2 mice
showed increased sensitivity to LPS and a 50% mortalityFigure 1. Generation of TNFDARE Mice
rate at a dose of 100 mg/25 g mouse (5 dead/group of(A) Structure of the TNF/LTa locus on mouse chromosome 17. (B)
10 TNFDARE/2 versus 0/10 TNF1/2 mice). In contrast, al-The TNFDARE targeting vector and (C) the predicted TNFDAREneo mutated
most all TNF1/2 mice survived up to a dose of 400 mg/locus in embryonic stem cells. Filled boxes represent exons, and
gray-shaded boxes represent UTRs. The position of TNF AU-rich 25 g mouse (1/9 TNF1/2 versus 7/9 TNFDARE/2). These
elements (ARE) is indicated (dark circle); open boxes denote the results show that in the absence of the ARE, acute and/
selection marker genes. Filled arrowheads indicate the position of or chronic overproduction of TNF in vivo sensitizes the
the loxP sequences. The location of the external and the internal 39
animals to the lethal effects of LPS.probes ([A] and [B], respectively) are also shown. Restriction enzyme
sites are as follows: Bg, BglII; Bs, BstEII; S, SacI; K, KpnI; N; NdeI;
No, Not. (D) Predicted structure of the mutated TNFDARE locus follow- ARE Modulate the Stability of TNF mRNA
ing Cre-mediated excision of the neo marker gene via site-specific Macrophages are the most prominent source of TNF
recombination on the flanking loxP sequences. (E) Southern blot production in vivo. We have thus chosen this specific
analysis of SacI-digested tail DNA from TNFDAREneo heterozygous F1
cell type to address the involvement of the ARE in themice probed with a 39 0.6 kb AccI probe. The positions of the mutant
regulation of TNF biosynthesis. Thioglycollate-elicited6.2 kb and wild-type 4.9 kb fragments are indicated. (F) Southern
peritoneal macrophages (TEPM) and bone marrow±blot analysis of BglII-digested tail DNA from TNFDARE heterozygous
F1 mice following Cre-mediated excision of the neo marker, de- derived macrophages (BMDM) were selected for our
tected with a 39 0.4 kb BglII probe. The neo1 (1.6 kb), neo2 (0.5 kb), analyses. These macrophage populations were iso-
and the wild-type (0.4 kb) fragments are indicated. lated from both the original TNFRI1/1 and disease-free
TNFRI2/2 background (see below) to eliminate the possi-
bility that alterations in TNF biosynthesis in the mutantResults
cells may result from chronic inflammation occurring at
the in vivo sites of origin.Generation of TNFDARE Mice
A 69 bp deletion encompassing the TNF ARE was tar- At the protein level, both TEPM and BMDM from
TNFDARE mice spontaneously produce readily detectablegeted in embryonic stem cells together with the neomy-
cin resistance marker (neo) flanked by loxP sequences quantities of TNF protein compared to those derived
from TNF1 cultures, which were consistently lower than(Figures 1A±1C). Transient expression of Cre recombi-
nase in fertilized oocytes from these mice resulted in the the detection limit of our ELISA (40 pg/ml) (Table 1). In
addition, a 3- to 5-fold increase in TNF protein produc-excision of the neo gene and the generation of TNFDARE
mouse lines (Figure 1D). Homozygous TNFDARE/DARE mice tion, measured 9 hr after LPS stimulation, was detected
in macrophage supernatants derived from TNFDARE com-displayed early severe pathological manifestations and
exhibited a reduced life span (see below). To circumvent pared to TNF1 mice. Therefore, in the absence of an
intact ARE, TNF protein production by macrophagesthis problem, the effects of the TNFDARE mutation on TNF
biosynthesis were studied in compound hemizygous remains responsive to LPS stimulation. Moreover, the
absence of ARE has an overall enhancing effect on TNFTNFDARE/2 animals generated by crossing TNFDARE/1 to
TNF2/2 mice (Pasparakis et al., 1996b). The use of the production by macrophages.
To assess the level(s) at which regulation of TNF bio-hemizygous TNFDARE/2 mice in these experiments al-
lowed the investigation of the regulatory role of the ARE synthesis is affected by the ARE mutation, we compared
kinetics of mRNA production in TNFDARE/2 and TNF1/2element in a monoallelic system devoid of interference
by a wild-type TNF allele on TNF production. TEPM (Figure 2). Using Northern analysis, TNF1 mRNA
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Table 1. Ex Vivo Spontaneous and Induced TNF Protein Production by TNFDARE Hemopoietic Cells
TNF1/2a TNFDARE/2 TNF1/1/TNFRI2/2 TNFDARE/DARE/TNFRI2/2
TEPMb
Nonstimulated ,0.04e 0.30 6 0.15 ,0.04 0.23 6 0.08
LPS 7.87 6 2.70 25.04 6 8.86 11.56 6 4.55 41.91 6 7.52
BMDMc
Nonstimulated ,0.04 0.09 6 0.06 ,0.04 0.242 6 0.12
LPS 7.62 6 2.64 27.37 6 2.85 10.10 6 1.86 51.09 6 15.76
T cellsd
Nonstimulated 0.76 6 0.09 1.44 6 0.27 0.56 6 0.4 1.57 6 0.5
Anti-CD3 3.37 6 0.9 10.73 6 2.98 5.09 6 1.08 16.75 6 3.69
Macrophages (5 3 105 adherent cells) and T lymphocytes (5 3 106 cells/ml) were cultured in the presence or absence of LPS (1 mg/ml) or
anti-CD3 (10 mg/ml) in medium for 24 hr, and culture supernatants were collected for TNF protein detection using ELISA.
a Values (means 6 SD) in ng/ml from one of three representative experiments with eight mice per group.
b Thioglycollate-elicited peritoneal macrophages.
c Bone marrow±derived macrophages.
d Nylon wool±enriched splenic T cells.
e Detection limit.
could be detected at low quantities in resting macro- TNF protein production was also observed in splenic
B220-panned lymphocytes in the presence or absencephages; its levels were rapidly increased 90-fold at its
peak at 1 hr after LPS induction and quickly returned of mitogenic stimulation (data not shown). These results
show that in addition to the macrophages, TNF produc-to baseline between 3 and 6 hr (Figure 2A). In contrast,
TNFDARE mRNA showed an approximately 2.7-fold in- tion in other hemopoietically derived cells is equally af-
fected by the absence of the ARE.crease in resting macrophages, reached a 148-fold in-
duction at its peak at 3 hr after LPS induction, and slowly
returned to baseline well past 9 hr. The corresponding The ARE Is a Target for the Regulation of TNF
Biosynthesis by the p38/SAPKtranscriptional rates at 0, 1, 3, and 6 hr after LPS stimula-
tion were similar for both TNFDARE and TNF1 alleles (Fig- and JNK/SAPK Pathways
LPS signal transduction in monocytes and macro-ure 2B). At 1 hr after LPS stimulation, the 5-fold increase
in the rate of wild-type TNF gene transcription correlated phages has been shown to involve activation of the
mitogen-activated protein kinases (MAPK), p38, p42/44with a 90-fold increase in the steady-state TNF mRNA
levels. Notably, in the absence of the ARE, a similar (ERK), and p54 stress-activated protein kinase/c-Jun
N-terminal kinase (SAPK/JNK) (Lee et al., 1994; Ham-5-fold increase in transcription resulted in a 46-fold in-
crease in steady-state TNFDARE mRNA levels, indicating bleton et al., 1995; Swantek et al., 1997). The observation
that selective inhibition of the p38/SAPK with specifica much reduced yet existent posttranscriptional regula-
tion. We further examined whether a proposed mecha- imidazole compounds prevents translation of TNF
mRNA in macrophage cell lines (Prichett et al., 1995)nism of induced splicing of pre-mRNA (Yang et al., 1998)
could explain the difference in accumulation of TNFDARE prompted us to investigate the possibility of a direct
interaction of this pathway with TNF ARE. Treatment ofmRNA in macrophages. Induced accumulation (within
15 min of LPS stimulation) and rapid disappearance (by TNF1/2 TEPM for 9 hr with LPS plus the p38/SAPK inhibi-
tor SB203580 resulted in a marked dose-dependent inhi-1 hr after LPS stimulation) of both TNF1 and TNFDARE
pre-mRNA could be observed (Figure 2D), suggesting bition of LPS-induced TNF protein secretion (Figure 3A),
whereas no change in the levels of TNF1 mRNA werethat pre-mRNA splicing mechanisms are not affected
by the absence of the ARE in macrophages. Taken to- detected 3 hr after LPS 1 SB203580 (Figure 3B). Inter-
estingly, similar treatment of TNFDARE/2 macrophages hadgether, these results indicate that in the absence of
stimulation, ARE act as determinants of TNF mRNA in- no effect on either TNF secretion or mRNA accumula-
tion, thereby demonstrating a requirement for the AREstability. However, following LPS stimulation, the ARE
mediate posttranscriptional enhancement of TNF mRNA region in the p38/SAPK-mediated activation of TNF
translation.accumulation. Calculation of the decay rates for both
the wild-type and mutant TNF mRNAs following their Recent studies have shown that dexamethasone
(Dex) inhibits TNF translation via selective blocking ofpeak accumulation, at 1 and 3 hr, respectively, revealed
a 4-fold increased half-life for the mutant TNF mRNA the JNK/SAPK pathway (Swantek et al., 1997). Signifi-
cantly reduced levels of TNF protein were measured(TNF1 mRNA t1/2 5 88 min versus TNFDARE mRNA t1/2 5
353 min) (Figure 2C). Therefore, following peak accumu- from LPS-induced TNF1/2 TEPM in the presence of Dex;
this inhibition occurred in a dose-dependent mannerlation of TNF mRNA, ARE-mediated negative regulatory
mechanisms reestablish default TNF mRNA instability. and reached $90% inhibition at 10 mM (Figure 3C). At
the same dose, Dex was found to also reduce the levelsSimilar to what was found in macrophages, TNFDARE/2
spleen-derived, nylon wool±enriched T lymphocytes of steady-state TNF1 mRNA by 90% (Figure 3D), con-
firming previous studies reporting the inhibitory effectproduce three times more TNF protein (Table 1) and
display prolonged mRNA accumulation profiles (data of Dex on TNF transcription (Beutler et al., 1986). Treat-
ment of TNFDARE/2 TEPM with Dex resulted in a similarnot shown) relative to TNF1/2 cultures upon incubation
with an agonistic anti-CD3 antibody (Table 1). Increased reduction in mRNA values. However, even at a maximal
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Figure 2. Effect of TNFDARE Mutation on TNF
Biosynthesis in Macrophages
(A) Detection of steady-state TNF mRNA in
TNFDARE/2 (closed bars) and TNF1/2 (hatched
bars) macrophages. Total RNA (5±10 mg) from
exudate peritoneal macrophage preparations
was analyzed on Northern blots. RNA was
extracted from adherent cells before (0) or at
various time points after stimulation with 1
mg/ml LPS. The bar graph shows the results
(mean 6 SD) from four independent experi-
ments following scanning quantitation. Data
have been normalized according to b-actin
values.
(B) Analysis of TNF transcription rate in
TNFDARE/DARE/TNFRI2/2 (closed bars) and
TNFRI2/2 control (hatched bars) macro-
phages. Nuclei run-on experiment with la-
beled RNAs obtained from nuclei prepared
from exudate peritoneal macrophages treated
as above in the presence or absence of LPS.
RNAs were hybridized with DNA fragments
corresponding to mTNF cDNA (1.6 kb) and
b-actin (0.9 kb PstI fragment) all spotted on
the same filters; all filters were split in half
and hybridized with 2 3 106 cpm RNA per
milliliter. The bar graph shows results (mean 6
SD) from two experiments quantitated and
normalized to b-actin values.
(C) Decay of TNFDARE (closed circles) and TNF1
mRNAs (open circles) as assessed by the
Northern analysis in (A). The results are ex-
pressed as percentage of density units from
the peak of mRNA accumulation. Half-lives
were calculated from the regression (dotted)
lines of individual data sets.
(D) Detection of TNF pre- and mature mRNA
in macrophages. Semiquantitative RT±PCR
analysis on total RNA obtained from TNF1/2
(left) and TNFDARE/- exudate peritoneal macro-
phages before (0) and at various time points
after LPS stimulation. Results shown as
Southern blots from PCR products run on 2%
agarose gel and hybridized with cloned mTNF
(0.9 kb Nar±BglII) and mGAPDH (0.17 kb AccI)
fragments.
(E) Kinetics of TNF protein production per hour. Supernatants of TNFDARE/- (closed bars) and TNF1/2 (hatched bars) exudate peritoneal
macrophage cultures (5 3 105 adherent cells/ml medium) were collected at the hourly intervals before and after LPS stimulation, as before.
Following each sample collection, cells were washed and incubated with fresh LPS-containing medium. TNF protein levels were assessed
by ELISA. Data shown from a representative of three experiments from macrophages obtained from individual mice (n 5 8). The time points
shown correspond to the examined steady-state mRNA points examined earlier.
(F) Graphical correlation between the accumulation of TNFDARE (open circles) and TNF1 (closed circles) mRNAs (dotted lines) and corresponding
protein production (continuous lines) in the presence of LPS. Results shown as percentages of TNF1 maxima.
dose of 10 mM Dex, protein production from TNFDARE evident that TNF ARE regulate the translational activa-
tion but not the translational efficiency of the TNFmRNA could not be reduced to more than 50% of control
levels, indicating a defect in the translational repression. message.
Similar results were also obtained in BMDM from TNF1/2
and TNFDARE/2 mice as well as from macrophages derived
from TNFDARE/DARE/TNFRI2/2 mice (data not shown). Taken Absence of ARE Renders Nonhemopoietic
Tissues Permissive for TNF Productiontogether, these results establish the ARE as a specific
target for the LPS-induced translational activation of Earlier studies have favored the hypothesis that the ARE
imposes a permanent dominant translational repressionTNF biosynthesis by the p38/SAPK and JNK/SAPK
modules. in nonhemopoietic cells (Kruys et al., 1993). We have
therefore analyzed TNF biosynthesis in isolated primaryNotably, correlation of the levels of TNF protein pro-
duced per hour to the levels of the corresponding fibroblast cultures derived from the synovium and lung
of TNFDARE/2 and TNF1/2 mice for spontaneous or LPS-TNFDARE and TNF1 mRNAs did not show significant differ-
ences (Figures 2E and 2F), suggesting that the absence stimulated TNF expression. Using RT±PCR, the pres-
ence of TNF1 mRNA was observed in cultured fibro-of ARE does not influence the rate of translation of the
mutant mRNA following LPS stimulation. It is therefore blasts from both lung and synovium. A higher level of
Role of TNF ARE in TNF Biosynthesis and Disease
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Figure 3. Effect of p38 and JNK/SAPK Inhibition on LPS-Induced TNF Production by Macrophages
TNFDARE/2 (closed circles) and TNF1/2 (open circles) TEPM's (5 3 105 adherent cells/ml) were stimulated with LPS (1 mg/ml) for 12 hr in the
presence of various concentrations of the p38/SAPK inhibitor SB203580 (A) or dexamethasone (Dex) (C); TNF levels in supernatants were
determined by ELISA. Northern analysis and quantitation of total RNA isolated from pooled (n 5 4) TNFDARE/2 (closed bars) and TNF1/2 (hatched
bars) macrophage cultures in the absence or presence of 10 mM SB203580 (B) or 10 mM dexamethasone (D). Results shown as percentages
of LPS alone; values from three experiments with macrophages derived from individual mice (n 5 8 mice/group/experiment).
TNFDARE mRNA could be recorded in either culture, indi- TNFDARE Mice Are Growth Retarded and Develop
Chronic Inflammatory Arthritis andcating enhanced mRNA accumulation in the absence of
Inflammatory Bowel Diseasethe ARE (Figure 4A). Spontaneous TNF protein secretion
Homozygous TNFDARE/DARE mice show a severely reducedcould readily be detected in both synovial and lung
weight gain and increased mortality in comparison toTNFDARE/2 and TNFDARE/DARE/TNFRI2/2 fibroblast cultures
heterozygous TNFDARE/1 and normal littermate controls.(Figure 4A). LPS stimulation of TNFDARE/2 fibroblast cul-
Homozygous mice never exceeded 6±7 g of body weighttures resulted in a further 2-fold increase in the levels
and succumbed to disease between 5 and 12 weeks ofof TNF mRNA and a 3-fold increase in TNF protein levels
age. In addition, these mice develop clinical evidence ofcompared to unstimulated controls. In contrast, TNF1/2
chronic polyarthritis, presenting with swelling of severalfibroblasts did not show any detectable changes in the
joints and distortion of front and rear paw morphology,levels of TNF mRNA or protein following LPS treatment.
which leads to a severe impairment in movement. Histo-Due to the very low levels of TNF mRNA in the TNF1/2
logical examination performed at different develop-fibroblasts, it has remained unclear whether the inability
mental stages in major organs of the TNFDARE/DARE andof this specific cell type to produce TNF protein results
TNFDARE/1 mice revealed the evolvement of two specificpredominantly from translational repression or from the
chronic pathologies, i.e., inflammatory arthritis and in-absence of a significant RNA pool. We have thus isolated
flammatory bowel disease. Other organs from thesesynovial fibroblast-like cell cultures from a transgenic
mice such as liver and lung showed occasional evidence
mouse line carrying a high copy number of a wild-type
of mild inflammation, but tissue architecture was always
human TNF transgene (Keffer et al., 1991). In these
well preserved. Thymi in 4-week-old TNFDARE/DARE mice
transgenic mice, production of human TNF by TEPM were severely hypoplastic and showed atrophied and
parallels that of the endogenous murine TNF both in the disorganized cortical and medullary areas. However,
absence or presence of LPS (Figure 4B). In contrast, flow cytometric analysis of 12-day-old TNFDARE/DARE thymi
despite the presence of a high level of human TNF mRNA and peripheral blood did not reveal any perturbation in
in synovial fibroblast-like cells, no human TNF protein the ratio of T cell subsets.
could be detected, indicating permanent suppression In agreement with macroscopic observations, the
of translation. Taken together, these results suggest that joints of TNFDARE mice displayed severe pathological fea-
in synovial or lung fibroblast-like cells (conceivably per- tures of chronic symmetrical inflammatory polyarthritis.
haps in other nonhemopoietic tissues as well), transla- The histological onset of the disease occurs earlier than
tion of wild-type TNF mRNA is silenced by the presence 12 days postnatally in TNFDARE/DARE mice and at 6±8 weeks
of the ARE region. Conversely, in the absence of the of age in TNFDARE/2 mice. Early arthritic features include
ARE, this translational control is no longer operative, hyperplasia of the synovial membrane and the presence
of polymorphonuclear infiltrates. At later stages, pannusresulting in the spontaneous production of TNF protein.
Immunity
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to the terminal ileum and occasionally to the proximal
colon. The initial lesions consisted of mucosal abnor-
malities with intestinal villous blunting and broadening.
These changes were associated with mucosal and sub-
mucosal infiltration of chronic as well as acute inflamma-
tory cells, including mononuclear leukocytes, plasma
cells, and scattered neutrophils. Severe intestinal in-
flammation was observed by 4 weeks in TNFDARE/DARE and
8 weeks in TNFDARE/1 mice. An increased number of sub-
mucosal lymphoid aggregates and follicles were also
evident at this time. As the disease progressed, the
inflammatory infiltrate extended deep into the muscular
layers of the bowel wall, with characteristics typical of
transmural inflammation (Figure 5B). In aged TNFDARE/1
mice (4±7 months old), complete loss of villous struc-
tures as well as rudimental granulomata resembling non-
caseating granulomas with multinucleated giant cells
were observed (Figure 5C). Overall, the histopathologi-
cal findings in the intestines of TNFDARE mice closely
resemble those observed in patients with Crohn's dis-
ease (Figure 5D).
Differential Role for TNFRII in the Modulation
of Chronic Inflammatory Arthritis and
Crohn's-like Pathology in TNFDARE Mice
To analyze the contribution of the two TNF receptors to
disease development in the TNFDARE mutant mice, we
have introduced the TNFDARE mutation into a TNFRI-
or TNFRII-deficient genetic background (Rothe et al.,
1993; Erickson et al., 1994). Double homozygous mice
(TNFDARE/DARE/TNFRI2/2) develop normally, showing no ap-
parent signs of macroscopic illness. Histopathological
evaluation of mice at 1, 3, 6, and 8 months showed
Figure 4. Spontaneous TNF Production by TNFDARE Lung and Syno-
complete neutralization of all pathological complica-vial Fibroblasts
tions, including intestinal and joint pathologies (Figures(A) TNF1/2 (open bars), TNFDARE/2 (closed bars), and TNFDARE/DARE/
5F and 6B). In contrast, TNFDARE mice bred into a TNFRII-TNFRI2/2 (hatched bars) fibroblast cultures derived from lung (LF)
and synovial (SF) tissue were examined by ELISA for the presence deficient background did not show clinical improvement
of TNF protein production in culture supernatants (105 adherent in comparison to TNFDARE/1/TNFRII1/2 controls. On the
cells/ml) in the presence or absence of LPS (1 mg/ml) stimulation contrary, these mice showed a much more aggressive
(pooled cultures of five animals per group). Values are mean (6 SD)
and destructive type of arthritis, which was clinicallyfrom at least three representative experiments. Detection of TNF
evident with enhanced swellings of the joints. At themRNA via RT±PCR from total RNA derived from the above fibroblast
histological level, double TNFDARE/1/TNFRII2/2 mice ex-cultures. Shown are Southern blots of the PCR products hybridized
with muTNF- and GAPDH-specific probes. (B) Detection of hTNF hibited an exacerbated synovial hyperplasia with in-
protein and mRNA in synovial fibroblasts (SF) and TEMPs (MF) ex- creased numbers of polymorphonuclear infiltrates and
pressing an hTNF transgene in the presence or absence of LPS (1 generally enhanced destruction of bone and cartilage
mg/ml). Shown are ELISA values from three separate experiments
in comparison to littermate controls (Figure 6C). Theseand Northern analysis with an hTNF (0.6 kb EcoRI±NarI) genomic
data indicate an overall suppressive role for TNFRII infragment; b-actin signals are shown for comparison.
the development of arthritic disease in this model. Nota-
bly, however, examination of TNFDARE/1/TNFRII2/2 intesti-
nal tissues at 1±5 months of age revealed a markedand fibrous tissue formation, subchondral bone erosion,
attenuation of gut pathology, with only mild inflamma-and articular cartilage destruction are observed (Figure
tory changes localized to the mucosa and submucosa.6A). All pathological characteristics were compatible
No evidence of transmural inflammation, increasedwith human rheumatoid arthritis, including the presence
number of lymphoid aggregates, or granulomatousof rheumatoid factors (both IgM and IgG) (data not
structures was detected compared to age-matchedshown).
TNFDARE/1/TNFRII1/2 controls (Figure 5G). Taken to-Systematic histological analysis of the gastrointesti-
gether, these results demonstrate a dominant role fornal tract revealed profound inflammatory changes con-
TNFRI in mediating the TNFDARE pathologies and revealsistent with a Crohn's disease±like phenotype (Figure
a differential role for TNFRII in modulating pathogenesis5). These alterations were first detected in TNFDARE mice
between 2 and 4 weeks of age and were localized primarily of chronic inflammatory arthritis and IBD in this model.
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Figure 5. Inflammatory Bowel Disease in
TNFDARE Mice Resembling Human Crohn's
Disease
Histologic examination of portions of ileum
from mice in different experimental groups.
(A) TNF1/1 control at 8 weeks. The villus
height and inflammatory component are
normal.
(B) TNFDARE/DARE homozygote at 7 weeks. The
changes are similar to those in the heterozy-
gote 24 week animal. Villi are blunted and
distorted, with a marked inflammatory infil-
trate composed of lymphocytes, plasma
cells, scattered neutrophils, and collections
of submucosal histiocytes forming rudimen-
tary granulomata.
(C) TNFDARE/1 heterozygote at 16 weeks. There
is villous blunting and chronic inflammation.
An ill-defined noncaseating granuloma is
present within the submucosa (arrowhead).
(D) Ileocecal region from a human with
Crohn's disease. Note the similar location
and composition of the granulomata (arrow)
compared with the mouse model.
(E) TNFDARE/1 heterozygote at 16 weeks. There
is villus blunting with marked acute and
chronic inflammation extending transmurally.
An ill defined noncaseating granuloma is
present within the submucosa (arrowhead).
(F) TNFDARE/DARE/TNFRI2/2 double homozygote
at 12 weeks. There is normal intestinal ap-
pearance with preserved villi, minimal chronic
inflammation confined to the mucosa, and
unremarkable muscularis.
(G) TNFDARE/1/TNFRII2/2 at 16 weeks. There is
a modest villous blunting with mild chronic
inflammation and few neutrophils in the lam-
ina propria without transmural inflammation.
(H) TNFDARE/1/RAG12/2 at 12 weeks. There is
mild patchy villous blunting and widening
with a modest, almost normal chronic inflam-
matory infiltrate in the lamina propria only.
There is no acute inflammation, nor is there
acute inflammation in the muscularis muco-
sae or submucosa.
Hematoxylin and eosin staining. Magnifica-
tion, 3150.
Differential Contribution of Mature T and B Cells immune mechanisms are therefore responsible for the
development of arthritis and IBD in the TNFDARE model.in the Pathogenesis of TNF-Mediated Joint
and Gut Pathology in TNFDARE Mice
Taking advantage of the simultaneous occurrence of Discussion
two specific TNF-mediated pathologies in the same ani-
mal model, we wished to address the role of the adaptive TNF ARE as Determinants of TNF mRNA Stability
ARE from early response genes (ERGs), proto-onco-immune response in this system. Introduction of the
TNFDARE mutation into a RAG1-deficient background genes, and cytokine mRNAs (Chen and Shyu, 1995) have
been demonstrated to confer instability in chimeric re-(Mombaerts et al., 1992) led to the generation of double
mutant animals. RAG1-deficient TNFDARE/1 mice dis- porter mRNAs. Previous studies, however, failed to
show a role of the 39-UTR/ARE on TNF message instabil-played full clinical and histopathological signs of chronic
destructive inflammatory arthritis (Figure 6D). In sharp ity (Han et al., 1991b; Jacob et al., 1996). Our findings
demonstrate that the absence of the ARE region resultscontrast, the Crohn's-like intestinal phenotype was al-
most completely prevented in RAG1-deficient TNFDARE/1 in increased steady-state TNF mRNA levels (Figures 2A
and 3A) in both hemopoietic and stromal tissues, estab-mice, with only minimal villous blunting and mild inflam-
matory changes limited to the intestinal mucosa (Figure lishing TNF ARE as determinants of TNF mRNA instabil-
ity in unstimulated conditions.5H). Taken together, our findings demonstrate that in
contrast to chronic inflammatory arthritis, the presence Determination of mRNA stability by ARE sequences
in stimulated conditions appears complex and cannotof mature T and B cells play a major role in the develop-
ment of the IBD pathology in TNFDARE mice. Differential be explained by static properties conferred by these
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Figure 6. Chronic Inflammatory Polyarthritis
in TNFDARE Mice
Histologic examination of ankle joints from
mice in different experimental groups.
(A) TNFDARE/DARE homozygote at 7 weeks; the
formation of the inflammatory pannus and ar-
eas of cartilage and bone erosion are evident.
(B) TNFDARE/DARE/TNFRI2/2 double homozygote
at 7 months; no apparent signs of arthritis are
observed.
(C) TNFDARE/1/TNFRII2/2 double mutant mice
at 12 weeks; increased tissue destruction is
evident, resembling the homozygote at 7
weeks.
(D) TNFDARE/1/RAG12/2 double mutant at 12
weeks; arthritis similar to TNFDARE/1/RAG1/2
controls.
Hematoxylin and eosin staining. Magnifica-
tion, 340.
elements on the half-life of the mRNA, but rather by support the concept that ARE sequences play a critical
role in allowing the interplay of both positive and nega-their active involvement in biphasic positive±negative
regulatory loops. Initially, during the induction phase tive factors to determine the ordered functioning of sta-
bilization and destabilization phenomena to occur.of gene expression, it appears that ARE mediate the
stabilization of the respective mRNAs, leading to the
accumulation of increased quantities of steady-state TNF ARE as Determinants of TNF
mRNA TranslationmRNA (Figures 2A and 2B). ARE-mediated stabilization
should rely on a positively enforced mechanism, since One of the most important mechanisms regulating TNF
production that seems fully operative in quiescent mac-fold stabilization of TNF mRNA is higher in the presence
than in the absence of the ARE. It is noteworthy, how- rophages is translational inhibition, which was previously
shown to involve sequences present in the 39-UTR ofever, that even in the absence of ARE, TNFDARE mRNA
is still responsive to LPS-mediated stabilization. There- TNF mRNA (Han et al., 1990, 1991a). Here, the profound
capacity of TNFDARE macrophages and T cells to producefore, it is possible that in addition to the ARE, other
sequences mediate LPS-inducible and ARE-indepen- TNF indicate permissive translation and confirm that the
ARE should act as repressive elements in these specificdent TNF mRNA stabilization. On the other hand, follow-
ing a brief pulse of induction, destabilization mecha- cell types. However, although it appears that transla-
tional repression is reversible following stimulation ofnisms appear to be reinforced on the ARE, resulting in
the rapid clearance of the wild-type message. Our data hemopoietic cells by appropriate inducers, it seems to
operate permanently in nonhemopoietic tissues. A pre-provide evidence that TNF ARE is involved in such nega-
tive feedback mechanisms, since, in its absence, vious report suggested that in the latter cell types, TNF
production may be totally prohibited due to either tran-TNFDARE mRNA shows a delayed onset of decay. Interest-
ingly, induction of TNF mRNA destabilization has been scriptional restraints such as methylation or extinction
of induced signaling pathways (e.g., LPS), leading todemonstrated following thalidomide or PKC inhibitor ad-
ministration in stimulated monocytes (Moreira et al., irreversible translational silencing (Kruys et al., 1993).
We were able to detect wild-type TNF mRNA in wild-type1993) or astrocytes, respectively (Lieberman et al.,
1990). It is therefore possible that these compounds synovial and lung fibroblast cultures, demonstrating that
transcription is not hampered in such cells. However,necessitate the ARE to exert their function. Furthermore,
tristetraprolin (TTP), a zing finger±containing protein, despite detectable levels of wild-type TNF mRNA, pro-
tein production remained undetectable, confirming thewas recently shown to bind to AREs from several
mRNAs, and its function was associated with negative translational silencing hypothesis. In addition, irrevers-
ible translational silencing of wild-type TNF mRNA inregulation of the stability of the TNF message (Carballo
et al., 1998). RNA stabilization by another family of pro- LPS-treated synovial fibroblasts could be demonstrated
by transgenic overproduction of a wild-type TNF mRNA,teins that show ARE binding activity, the HuR/ELAV fam-
ily of proteins, has also been demonstrated recently which could not be translated in these cells (Figure 4B).
In the absence of the ARE, however, both synovial and(Peng et al., 1998), providing an example of an inducible
factor operating on the ARE probably during the induc- lung fibroblasts readily expressed enhanced levels of
TNF mRNA and significant quantities of TNF protein,tion/stabilization phase of the response. These data
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indicating permissive translation. Although not ad- unresponsive to anti-inflammatory modulation, and fail-
ure to regulate this important homeostatic mechanismdressed directly, increased RNA accumulation in the
fibroblast should result from delayed decay kinetics in in the gut may result in the Crohn's-like phenotype char-
acteristic of the TNFDARE model.the absence of the ARE, as demonstrated for the macro-
phage. On the other hand, arthritis in TNFDARE mice develops
even in the absence of a mature lymphocytic componentThe present experiments confirm earlier studies
showing that translational activation is a significant or even in the absence of significant gut pathology (e.g.,
in the RAG2/2 background). Our results suggest that themechanism accounting for the rapid induction of TNF
protein production following LPS administration (Beutler arthritic events occurring in the joints of the TNFDARE mice
are driven by the spontaneous capacity of synoviocyteset al., 1986) and assign a pivotal role for SAPK signals
in this phenomenon (Prichett et al., 1995; Swantek et to produce TNF due to the absence of ARE (Figure 3).
Similarly to the TNFDARE mice, synovial fibroblasts fromal., 1997). Most importantly, our data provide direct evi-
dence that, in at least the macrophage, the ARE serve arthritic hTNF 39-globin transgenic mice also express
high levels of TNF, and development of disease in aas targets for this type of signals, which therefore appear
to orchestrate the on/off properties of the translational RAG1-deficient background remains unaltered (Douni
et al., 1995). These data suggest parallel mechanismsrepressive capacity of the ARE. Negative regulation of
the SAPK pathways by a number of anti-inflammatory of arthritis development in the two models and point
toward the involvement of innate and/or stromal mecha-stimuli is therefore expected to target the ARE to medi-
ate suppression of TNF translation, and it is conceivable nisms in disease initiation and progression.
To our knowledge, no polymorphisms in the 39-UTRthat functional disturbances on the ARE machinery may
render translation of the TNF message unresponsive to of the TNF gene have so far been reported for humans.
Given the regulatory complexity of this region, mutationsanti-inflammatory modulation.
affecting the ARE function may involve other associated
factors. To that extent, it is interesting that the pheno-TNF ARE Mutation as an Etiopathogenic
type of mice lacking tristetraprolin (TTP) (Taylor et al.,Mechanism for IBD and Arthritis
1996), a factor which binds several ARE and appears toThe appearance of an organ-specific rather than sys-
also regulate TNF biosynthesis (Carballo et al., 1998),temic disease profile, i.e., mainly IBD and arthritis, indi-
shows partial resemblance to the TNFDARE model (i.e.,cates a tissue-specific pathogenic potential of the ARE
arthritis but not IBD). In addition to such geneticallymutation. The IBD phenotype present in TNFDARE mice
defined mutations, exogenous factors such as viral pro-histologically most closely resembles human Crohn's
teins showing modulatory activity on ARE (Brown et al.,disease. TNF has been suggested to significantly con-
1995) may also affect TNF biosynthesis and be causativetribute to intestinal damage in Crohn's disease by alter-
of disease.ing the integrity of epithelial and endothelial cell barriers,
increasing the recruitment of inflammatory cells, and
contributing to the formation of granulomas (reviewed Conclusions
Results reported in the present study clarify the regula-by van Deventer, 1997). In addition, the role of TNF has
been shown directly in several animal models of IBD in tory properties of TNF ARE in several biosynthetic
checkpoints and reveal the tissue-specific pathogenicwhich either anti-TNF treatments or its genetic ablation
results in the amelioration of mucosal inflammation (Po- potential of ARE mutations in whole animals. Our find-
ings demonstrate that (1) TNF ARE impose a destabiliz-wrie et al., 1994; Neurath et al., 1997). The essential role
of TNF in the pathophysiology of Crohn's disease has ing activity on the TNF message in unstimulated condi-
tions; (2) they contribute significantly to the permanentbeen unequivocally confirmed by the results of clear
clinical benefit seen in the use of a single dose of anti- (nonreversible) translational silencing of the TNF mes-
sage in nonhemopoietic tissues but also in the transientTNF monoclonal antibody in patients with active, ther-
apy-refractory Crohn's disease (Targan et al., 1997). suppression of TNF translation in hemopoietic tissues;
(3) following activation of hemopoietic cells by appro-Several animal models of IBD resembling ulcerative
colitis have been produced (Strober et al., 1998). A sug- priate stimuli, ARE regulate positively both stabilization
and translational derepression of the TNF message; (4)gested mechanism to explain disease pathogenesis in
these systems has been either the absence of a lympho- ARE serve as specific targets for translational activation
by JNK/SAPK and p38MAPK-mediated signals; and (5)cytic regulatory component or the expansion of a patho-
genic lymphocytic compartment (Powrie, 1995). We pro- ARE are required for the restoration of homeostasis in
TNF biosynthesis by mediating reinforcement of mes-vide evidence that Crohn's disease pathogenesis in the
TNFDARE mice requires the adaptive immune response sage destabilization and translational silencing follow-
ing the induction phase of the response. Absence ofand is dependent on the presence of both p55 and
p75TNF-R, the latter being a receptor expressed mainly this regulatory area from the mouse genome has led to
a profound temporal and spatial deregulation of TNFon hemopoietic cells (Santee and Owen-Schaub, 1996).
It may therefore be speculated that direct modulation production characterized by the persistent accumula-
tion and decreased rates of decay of the mutant TNFof hemopoietic cells by TNF is important in the mainte-
nance of immunological homeostasis in the gut. The mRNA and by its unresponsiveness to translational inhi-
bition in hemopoietic and stromal tissues. Remarkably,role of anti-TNF cytokines such as TGFb and IL-10 has
been also implicated in IBD (Shull et al., 1992; Kuhn this type of deregulation resulted in the development of
chronic inflammatory arthritis and inflammatory bowelet al., 1993). Thus, functional disturbances on the ARE
machinery may render translation of the TNF message disease, suggesting a possible link between a defective
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established by enzymatic treatment as previously described for hu-function of the ARE regulatory machinery and the devel-
man synovial tissue (Brennan et al., 1989). Fibroblasts were selectedopment of analogous pathologies in humans. Our finding
by continuous culturing for at least 20 days and a minimum of 3of a differential role of the two TNF receptors and of
passages. The uniformity of the cultures was assessed morphologi-
acquired immune mechanisms in the development of cally and by flow cytometry analysis for absence of myeloid (Mac-1)
the joint and gut pathology in the TNFDARE mice establish and lymphoid (CD3, B220) surface markers. For the experiments,
fibroblasts were plated at 5 3 105 cells/well in 24-well tissue culturethis model as a unique tool for further comparative stud-
plates in 1 ml of complete DMEM for the times indicated.ies on the pathophysiology of these two diseases.
TNF Protein Quantitation
Experimental Procedures Murine and human TNF immunoreactivity of sera (diluted 1/20±
1/50) and cultured supernatants (diluted 1/4 21/10) was measured
Animals using specific ELISAs as previously described (Pasparakis et al.,
All mice were bred and maintained on a mixed 129SvxC57BL/6 1996b). The sensitivity of these assays was at the range of 0.040±10
(targeted mutants) or CBAxC57BL/6 (transgenics) genetic back- ng/ml.
grounds and kept in the animal facilities of the Hellenic Pasteur
Institute under specific pathogen-free conditions.
RNA Analysis and Nuclear Run-On Assays
Total cellular RNA was extracted with the method of guanidinium
Targeted Deletion of TNF ARE Elements isothiocyanate (Chomczynski and Sacchi, 1987). For Northern blot,
The TNF locus consisting of the TNF, LTa, and LTb genes was a 0.9 kb 32P-labeled NarI±BglII genomic probe containing part of the
isolated from a 129/SvE mouse genomic library in lFixtmII vector first exon of the muTNF gene was used. This fragment is absent
(Stratagene). A 0.7 kb fragment containing most of the 39-UTR of from the TNF2/2 alleles (Pasparakis et al., 1996b).
the TNF gene was subcloned by EcoRI digestion into a pBluescript For RT±PCR analysis, the following combinations of primers were
(SK-) vector (Stratagene) and was used as a PCR template for a used for the detection of the corresponding mRNA's: mTNF, sense
site-directed deletion of 69 bp that contained 6 reiterated repeats 59-CACGCTCTTCTGTCTACTGAACTTCG-39 and antisense 59-GGC
of the (T)TAAAT(AT) motif. The following mutagenesis primer was TGGGTAGAGAATGGATGAACACC-39; Pre-mTNF amplifying a frag-
used for the deletion: 59-GAGCCAGCCCCCCTCGGAAGGCCGGG ment in the first exon/intron junction, 59-AACCAGGCGGTTCTGT
GTG-39. The final PCR product was digested with BglII to remove CCC-39 and 59-CTCTTGCTTATCCCCTCTTCC-39; hTNF, 59-TGCTGC
a 0.4 kb 39-UTR/DARE fragment, which was inserted back into the ACTTTGGAGTGATCGG-39 and 59-GGTTATCTCTCQAGCTCCAC
TNF 39-UTR cassette. For the TNFDARE targeting vector, a 1.2 kb GCC-39; and mGAPDH, sense 59-TCTTCTTGTGCAGTGCC-39 and
XhoI±SalI fragment from the pL2-neo plasmid containing the PMC- antisense 59-ACTCCACGACATACTCAGC-39. PCR reactions were
neo-poly(A) neomycin resistance cassette flanked by loxP se- performed for 25 cycles to avoid product saturation. Products were
quences (Gu et al., 1994) was inserted in the BstEII site located in subsequently diluted 1/20, resolved in 2% agarose gel, and blotted
the 39-UTR genomic sequence downstream of the DARE mutation. onto nylon membranes. Specific products were detected following
59 and 39 homology regions of 4.2 kb (KpnI±EcoRI TNF/LTa fragment) hybridization with specific 32P-labeled probes.
and 1.4 kb (EcoRI±NdeI 39TNF fragment) were inserted on either site Isolation of macrophage nuclei and nuclear run-on reactions were
of the modified TNF 39-UTR cassette. The final TNFDAREneo targeting performed as previously described (Linial et al., 1985). Slot blots
fragment was retrieved as a KpnI±NotI 6.5 kb fragment and was were prepared containing DNA fragments corresponding to mTNF
subcloned into a pNT plasmid (Tybulewicz et al., 1991) bearing a cDNA (1.6 kb) and b-actin (0.9 kb PstI fragment) as well as mGAPDH
herpes simplex virus thymidine kinase expression cassette. Tar- (0.17 kb AccI fragment) and pBluescript carrier plasmid control (data
geting procedures in CCE (129/SvE mouse strain) embryonic stem not shown), all spotted on the same filters (Hybond N1, Amersham).
cells and subsequent injections in C57BL/6 blastocysts were per- All filters were split in half and hybridized with an equal amount of
formed as previously described (Pasparakis and Kollias, 1995). Tar- labeled RNA (2 3 106 cpm/ml). Hybridization was performed for 48
geted clones were identified using Southern blot analysis with an hr in hybridization solution (50% formamide, 53 SSC, 53 Denhardt's
external AccI 0.69 kb probe (Figures 1A and 1E). Transient Cre solution, 0.02 M NaHPO4 [pH 6.5], 100 mg/ml heat-denatured
expression in the oocytes via microinjection of plasmid pMC-Cre- sheared salmon sperm DNA, and 10% dextran sulfate) at 428C with
polyA (Araki et al., 1995) resulted in germline excision of the neo 1 3 106 cpm/ml [32P]RNA. Blots were washed as described with an
gene, as assessed by genotyping of tail biopsies from the resulting RNAse step and autoradiographed for at least 48 hr at 2708C.
mice using a 0.4 kb BglII probe (Figures 1A, 1D, and 1F).
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